ClinicalTrials.Veeva

Menu

Remote Assessment of Outpatient With Severe Acute Respiratory Syndrome (SARS-CoV-2) (EVIDENCE)

U

University of Limoges (UL)

Status

Unknown

Conditions

SARS-CoV2 Infection

Treatments

Other: Questionnaire

Study type

Observational

Funder types

Other

Identifiers

NCT05125887
87RI21_0033/Evidence

Details and patient eligibility

About

Outpatient management of patients with a milder form of COVID may be associated to an unfavorable initial or deferred course in relation to the pathology.. Outpatients represent the bulk of patients with COVID-19. To know their evolution, their secondary complications and identifying a profile of "at risk" patients is essential for the prevention and care of future non-hospitalized patients, in an epidemic context still active.

This study could make it possible to redefine the follow-up of outpatients. The study consists of a simple questionnaire and possibly a teleconsultation.

Enrollment

400 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Patients with a PCR (polymerase chain reaction assay ) positive for Sars-COV-2 between the start of the pandemic and May 11, 2020
  • Outpatient care
  • Inclusion 24 months from the date of diagnosis of Sars-COV-2 (± 6 months)

Exclusion criteria

  • Patients in EHPAD (accommodation facilities for dependent elderly people), home, retirement home, center for disabled people
  • Patients under protective measure, curators or guardianship
  • Patients with a pathology or condition that does not allow them to express their wishes
  • Patients hospitalized when performing PCR or within 10 days with Sars-COV-2

Trial contacts and locations

1

Loading...

Central trial contact

LY Kim, MD; DUMONTEIL Stéphanie

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems